Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a promising therapeutic option for people with arthritis and obesity or type 2 diabetes mellitus owing to their pleiotropic effects, including weight loss, improved survival and reduced risk of major cardiovascular and renal events
Many of the patients from my medical weight management clinic who start on these agents express amazement and gratitude that they no longer think as much about food
Chinta Sidharthan Chinta Sidharthan is a writer based in Bangalore, India
In the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RA use was associated with lower risk among patients with recent psychiatric history, and no difference among patient without recent psychiatric history
Also, glutathione in an inhalant form can make asthma symptoms worse
Skin Brightening Promotes a clearer, more even complexion by reducing hyperpigmentation